← Eichor
Condition: Withdrawal Syndrome Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Withdrawal Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Phase 3 · 6 location(s) · Emory University · NCT05834478Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal
Phase 2 · 1 location(s) · University of Calgary · NCT04939623Impact of the Mandibular Advancement Device on Sleep Apnea During CPAP Withdrawal
NA · 1 location(s) · University Hospital, Angers · NCT05939934IWS Diagnosis Criteria Consensus
Phase N/A · 1 location(s) · ELIAS Emergency University Hospital · NCT07316894Validation of the French Version of the Prediction of the Alcohol Withdrawal Severity Scale (PAWSS)
Phase N/A · 1 location(s) · Etablissement Public de Santé Barthélemy Durand · NCT06675539Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
Phase 4 · 1 location(s) · The First Affiliated Hospital with Nanjing Medical Universit · NCT05461820Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal
Phase 2 · 2 location(s) · University of Pennsylvania · NCT05995535Kratom Use Disorder Management Using Clonidine and/or Buprenorphine
Phase N/A · 1 location(s) · Salem Anaesthesia Pain Clinic · NCT05883358Biologic Treatment Withdrawal in Takayasu Arteritis Patients in Sustained Remission
NA · 1 location(s) · Marmara University · NCT07491913Effect of Clinical and Biochemical Variables Over Morbidity and Mortality in Alcohol Withdrawal Syndrome Patients
Phase N/A · 1 location(s) · Hospital General de Mexico · NCT06589973Validating a Novel Driving Simulation-based MWT Against the Standard MWT in an OSA-cohort Challenged by CPAP-withdrawal
NA · 1 location(s) · Stefan Lakämper · NCT06872593Evaluation of the Electronic Cigarette Withdrawal Syndrome
EARLY_Phase 1 · 1 location(s) · Johns Hopkins University · NCT06066996Growth Hormone Replacement Therapy for Retried Professional Football Players
Phase 2 · 1 location(s) · Center for Neurological Studies · NCT04121780Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome
Phase N/A · 22 location(s) · HELP for NOWS Consortium · NCT07278375Metformin Withdrawal In Metabolic Syndrome
NA · 1 location(s) · University of Castilla-La Mancha · NCT07659444MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome
Phase N/A · 1 location(s) · Milton S. Hershey Medical Center · NCT05937594Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disor
Phase 1 · 1 location(s) · Proniras Corporation · NCT06538558
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.